Publisher and sponsors

Publisher 

LCC «Medicine-Inform»

Sponsorship and Reprint Policy

Involvement of leading Russian experts as authors, wide representation at all major events, high quality printing, and free distribution of the journal are possible due to partnerships with major Russian and foreign pharmaceutical companies.

Our sponsorship policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

1. To avoid the impact of sponsorship on the publication process Editors’ decisions do not depend on the amount of the contribution or the cost of producing reprints. Sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
2. The functions of editors and sales-managers in “Russian Medical Inquiry” journal are separate.
3. The publisher does not publish “advertorial” content, sponsored supplements are always marked as advertising. Sponsors’ banners and logos are always clearly visible and allow the sponsor to be uniquely identified.
4. “Russian Medical Inquiry” journal has the right to reject any sponsored supplements that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole. 
5. Any commercial relationship must be transparent to our users, so branded names of medicines may only be used in sponsored materials. Brand names are always accompanied by international generic or chemical names; the quantity of all active substances must be stated along with the recommended dosage.
6. When editorial office receives an article describing a study of a certain medicament, the author’s personal experience of using the medication, or a clinical observation of a patient treated with the help of a medicament, the editorial board invites a pharmaceutical producer of the medication to sponsor publishing the journal with the relevant article. The sponsorship allows the Editorial Board to shift cost-charges from authors who develop articles onto pharmaceutical companies (which is essential for low-income doctors and researchers in Russia). As a results all journal articles are published free of charge for its authors and readers. Sponsored articles are highlighted with clearly visible special mark of black triangle sign  that is placed at the end of the sponsored article. In addition to that a transcript ‘For publicity’ is addressed in imprint data at the 1st technical page of the journal. The editors also ensure that the share of sponsored articles doesn’t exceed a third part of the total number of articles in the issue. These articles go through a full cycle of review by the editors, the editorial board and the reviewer, which does not differ from the procedures for other articles. The potential conflict of interest of the authors is clearly indicated, even if the sponsors are not related to the published research, but sponsor the authors as lecturers or consultants.
7. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.